GW28-e0940 Comparison of drug-coated balloon versus drug-eluting stent in patients with drug-eluting stent in-stent restenosis: Insight from randomized controlled trials

GW28-e0940 Comparison of drug-coated balloon versus drug-eluting stent in patients with drug-eluting stent in-stent restenosis: Insight from randomized controlled trials

Objectives Both drug-coated balloon (DCB) and drug-eluting stent (DES) were used for treatment of in-stent restenosis but it is unclear about their effects of magnitude. There was no significant difference in major adverse cardiac events between groups (risk ratio, RR, 1.04, P = 0.699), myocardial i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-10, Vol.70 (16), p.C116-C116
Hauptverfasser: Liu, Wenhao, Wang, Shaohua, Xu, Chengzhang, Zhang, Haifeng, Lin, Yongqing, Chen, Yangxin, Wang, Jingfeng
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Clinical trials
Drug delivery
Implants
Restenosis
Stents
Surgical implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives Both drug-coated balloon (DCB) and drug-eluting stent (DES) were used for treatment of in-stent restenosis but it is unclear about their effects of magnitude. There was no significant difference in major adverse cardiac events between groups (risk ratio, RR, 1.04, P = 0.699), myocardial infarction (RR = 1.17, P = 0.598) and target lesion revascularization (RR = 1.24, P = 0.085) in overall analyses.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.07.409